Results 81 to 90 of about 376,110 (130)

Hemoperfusion Combined With Continuous Renal Replacement Therapy in the Management of ARDS COVID‐19 Patients: A Quasi‐Experimental Study

Health Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background and Aims Critically ill patients in COVID‐19 to the intensive care unit (ICU) may develop multiple organ dysfunction syndrome, with some requiring extracorporeal organ support. This study aimed to assess the effects of combined CytoSorb hemoperfusion (HP) and continuous renal replacement therapy (CRRT) on the improvement of the ...
Seyed MohammadReza Hashemian, Ameneh Jafari, Batoul Khoundabi, Hamidreza Jamaati, Payam Rahimi   +4 more
wiley   +1 more source

Analyse der Ulmer Datenbanken zum internationalen CytoSorb-Register: Dynamik der laborchemischen Leberparameter unter Anwendung des Hämadsorbers CytoSorb bei Patienten der herzchirurgischen Intensivstation

, 2023
Die generalisierte Inflammationsreaktion, die im Rahmen des Leberversagens vorkommen kann, führt im äußersten Fall zu multiplem Organversagen.
Reitmeier, Valerie
core   +1 more source

Simultaneous Treatment of Two Severe Acute Intoxication and Acute Kidney Injury

Seminars in Dialysis, Volume 38, Issue 2, Page 152-155, March/April 2025.
ABSTRACT Extracorporeal therapies could be required for treatment of life‐threatening severe acute intoxication. We present the case of an 82‐year‐old patient admitted to our Nephrology Unit because of metformin‐associated lactic acidosis (MALA) and acute kidney injury (AKI stage III AKIN criteria).
Fulvia Zappulo, Laura Martano, Ines Ullo, Veronica Catalano, Sara Donini, Anna Scrivo, Anna Laura Croci Chiocchini, Gaetano La Manna   +7 more
wiley   +1 more source

CytoSorb use in critically ill patients with hyperbilirubinemia

, 2021
CytoSorb, a relatively new blood purification technique is gaining popularity with different indications in critically ill patients. Our aim is to summarize currently available data on CytoSorb use in critically ill patients with acquired hepatic injury ...
Klementina Ocskay
core   +1 more source

Terapia de hemadsorción perioperatoria en endocarditis infecciosa: revisión sistemática y metaanálisis

Cirugía Cardiovascular
Resumen: La endocarditis infecciosa (EI) es una enfermedad sistémica con afectación multiorgánica. Se trata de una entidad grave, que con frecuencia requiere de tratamiento quirúrgico, a pesar del cual las tasas de mortalidad pueden ser elevadas debido a
Elio Martín Gutiérrez, Laura Castillo Pardo, Pasquale Maiorano, Bárbara Oujo González, Gregorio Laguna Núñez, José Manuel Martínez Comendador, Javier Gualis Cardona, Mario Castaño Ruiz   +7 more
doaj   +1 more source

The Revival of Sorbents in Chronic Dialysis Treatment

Seminars in Dialysis, Volume 38, Issue 1, Page 54-61, January/February 2025.
ABSTRACT Interest in the use of sorbents in chronic dialysis treatment has undergone a revival in the last decades, for which two major factors are responsible. The first is the potential of sorbents as adjunct therapy for the removal of substances that are difficult to remove by conventional dialysis therapies.
Jeroen Peter Kooman
wiley   +1 more source

Initial experience with CytoSorb therapy in patients receiving left ventricular assist devices

, 2022
BACKGROUND: The use of left ventricular assist devices (LVAD) in patients with advance heart failure is still associated with an important risk of immune dysregulation and infections.
Jef Van den Eynde, Peter Luedike, Thomas Chrosch, Markus Kamler, Alexander Weymann, Van den Eynde, Jef, Konstantin Zhigalov, Nikolaus Pizanis, Bastian Schmack, Achim Koch, Lukas Goerdt, Arian Arjomandi Rad, Goerdt, Lukas, Robert Vardanyan, Pizanis, Nikolaus, Kamler, Markus, Arjang Ruhparwar, Michel Pompeu Barros Oliveira Sá, Luedike, Peter, Arjomandi Rad, Arian; id_orcid, Alina Zubarevich, Zubarevich, Alina, Weymann, Alexander, Koch, Achim, Chrosch, Thomas, Zhigalov, Konstantin, Ruhparwar, Arjang, Vardanyan, Robert, Sá, Michel Pompeu Barros Oliveira, Schmack, Bastian   +29 more
core   +1 more source

Use of Hemoadsorption and Continuous Venovenous Hemodialysis With Enhanced Middle Molecule Clearance in Drug‐Induced Rhabdomyolysis

Case Reports in Critical Care, Volume 2025, Issue 1, 2025.
Drug‐induced rhabdomyolysis has become increasingly prevalent due to the rising use of medications such as statins, antidepressants, and antipsychotics. These can lead to muscle cell destruction and the release of myoglobin, potentially causing kidney damage.
Sebastian Hafner, Johannes Reins, Christoph Baader, Florian Balling, Sebastian Eff, Ricardo Jorge Dinis-Oliveira   +5 more
wiley   +1 more source

International registry on the use of the CytoSorb® adsorber in ICU patients [PDF]

, 2019
INTRODUCTION: The aim of this clinical registry is to record the use of CytoSorb® adsorber device in critically ill patients under real-life conditions. METHODS: The registry records all relevant information in the course of product use, e. g., diagnosis,
Singer, M, Olboeter, D, Träger, K, Molnar, Z, Nierhaus, A, Bach, F, Schott, M, Weyland, A, Nitsch, M, Friesecke, S, Baumann, A, Tomescu, D, Grigoryev, E, Kielstein, JT, Meier-Hellmann, A, Bogdanski, R, Kellum, J, Kogelmann, K, Born, F, Nestler, F, Quintel, M, Schittek, GA, Haake, H, Jacob, D, Brunkhorst, FM, Schumacher, U   +25 more
core  

Ticagrelor removal by CytoSorb® in patients requiring emergent or urgent cardiac surgery: a UK-based cost-utility analysis

, 2019
Background: Acute coronary syndrome patients receiving dual antiplatelet therapy who need emergent or urgent cardiac surgery are at high risk of major bleeding, which can impair postoperative outcomes.
Mortensen, E, Branagan‑Harris, M, Preissing, F, Adam, D, Rahimi, Kazem, Javanbakht, M, Rahimi, K, Trevor, M, Scheier, J, Cook, SF, Rezaei Hemami, M, Degener, F   +11 more
core   +1 more source